194 related articles for article (PubMed ID: 8724892)
21. Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts.
Redondo J; Bishop JE; Wilkins MR
Br J Pharmacol; 1998 Aug; 124(7):1455-62. PubMed ID: 9723958
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme inhibition prevents myocardial infarction-induced increase in renal cortical cGMP and cAMP phosphodiesterase activities.
Clauss F; Charloux A; Piquard F; Doutreleau S; Talha S; Zoll J; Lugnier C; Geny B
Fundam Clin Pharmacol; 2015 Aug; 29(4):352-61. PubMed ID: 25939307
[TBL] [Abstract][Full Text] [Related]
23. Extrarenal resistance to atrial natriuretic peptide in rats with experimental nephrotic syndrome.
Valentin JP; Ying WZ; Couser WG; Humphreys MH
Am J Physiol; 1998 Mar; 274(3):F556-63. PubMed ID: 9530272
[TBL] [Abstract][Full Text] [Related]
24. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes.
Wu CF; Bishopric NH; Pratt RE
J Biol Chem; 1997 Jun; 272(23):14860-6. PubMed ID: 9169455
[TBL] [Abstract][Full Text] [Related]
25. Effect of efflux of guanosine 3',5' cyclic monophosphate (cGMP) on the regulation of intracellular levels of cGMP in the inner medullary collecting duct.
Stoos BA; Garvin JL
Biochem Pharmacol; 1997 Mar; 53(5):631-6. PubMed ID: 9113081
[TBL] [Abstract][Full Text] [Related]
26. Effect of atrial natriuretic factor on renal cGMP production in rats with adriamycin-induced nephrotic syndrome.
Abassi Z; Shuranyi E; Better OS; Winaver J
J Am Soc Nephrol; 1992 Apr; 2(10):1538-44. PubMed ID: 1318109
[TBL] [Abstract][Full Text] [Related]
27. HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo.
Zhang PL; Jiménez W; Mackenzie HS; Guo J; Troy JL; Ros J; Angeli P; Arroyo V; Brenner BM
J Am Soc Nephrol; 1994 Oct; 5(4):1099-105. PubMed ID: 7849249
[TBL] [Abstract][Full Text] [Related]
28. Interactions between bradykinin and ANP in rat kidney in vitro: inhibition of natriuresis and modulation of medullary cyclic GMP.
Boric MP; Bravo JA; Corbalan M; Vergara C; Roblero JS
Biol Res; 1998; 31(3):281-9. PubMed ID: 9830516
[TBL] [Abstract][Full Text] [Related]
29. Maturation of A71915-dependent inhibition of atrial natriuretic peptide-stimulated cyclic GMP production in isolated rat glomeruli.
Norling LL; von Geldern T; Chevalier RL
Biol Neonate; 1994; 66(5):294-301. PubMed ID: 7873695
[TBL] [Abstract][Full Text] [Related]
30. Effects of hyperosmolality on ANP-stimulated cGMP generation in rat inner medullary collecting duct.
Shinohara M; Nonoguchi H; Ujiie K; Terada Y; Owada A; Tomita K; Marumo F
Kidney Int; 1994 May; 45(5):1362-8. PubMed ID: 7915340
[TBL] [Abstract][Full Text] [Related]
31. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC
J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803
[TBL] [Abstract][Full Text] [Related]
32. Renal interstitial cGMP mediates natriuresis by direct tubule mechanism.
Jin XH; Siragy HM; Carey RM
Hypertension; 2001 Sep; 38(3):309-16. PubMed ID: 11566896
[TBL] [Abstract][Full Text] [Related]
33. Renal hemodynamic and natriuretic effects of manganese and interactions with atrial natriuretic peptide.
Lafferty HM; Gunning M; Brady HR; Brenner BM; Anderson S
Am J Physiol; 1990 Apr; 258(4 Pt 2):F998-1004. PubMed ID: 2139546
[TBL] [Abstract][Full Text] [Related]
34. Effects of zaprinast on renal nerve stimulation-induced anti-natriuresis in anaesthetized dogs.
Sekizawa T; Shima Y; Yoshida K; Tanahashi M; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
Clin Exp Pharmacol Physiol; 1998 Dec; 25(12):1008-12. PubMed ID: 9887998
[TBL] [Abstract][Full Text] [Related]
35. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
Jespersen B
Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
[TBL] [Abstract][Full Text] [Related]
36. Modulation of ANP-dependent effects of endothelin by inhibitors of neutral endopeptidase and cGMP phosphodiesterase.
Valentin JP; Qiu C; Wiedemann E; Gardner DG; Humphreys MH
J Pharmacol Exp Ther; 1995 May; 273(2):744-52. PubMed ID: 7752077
[TBL] [Abstract][Full Text] [Related]
37. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
38. Augmentation of the natriuretic activity of exogenous and endogenous atriopeptin in rats by inhibition of guanosine 3',5'-cyclic monophosphate degradation.
Wilkins MR; Settle SL; Needleman P
J Clin Invest; 1990 Apr; 85(4):1274-9. PubMed ID: 2156897
[TBL] [Abstract][Full Text] [Related]
39. Ligand-dependent regulation of NPR-A gene expression in inner medullary collecting duct cells.
Cao L; Chen SC; Cheng T; Humphreys MH; Gardner DG
Am J Physiol; 1998 Jul; 275(1):F119-25. PubMed ID: 9689013
[TBL] [Abstract][Full Text] [Related]
40. Lack of effect of atrial natriuretic peptide and urodilatin on vasopressin-stimulated cyclic AMP production in microdissected rat inner medullary collecting ducts.
Burgess WJ; Perrott MN; Balment RJ
J Mol Endocrinol; 1994 Apr; 12(2):149-54. PubMed ID: 8060479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
